Cohort Divided into 3 Subgroups: Primary Staging, Follow-up or Adjuvant Therapy, and Progressive Disease or Recurrence
| Subgroup | Patients (n) | TNM staging | Oncologic management | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| No change | Downstaging | Mixed | Upstaging | Gliomas | No change | Minor change | Major change | No sufficient data | ||
| Primary staging | 48 | 26 | 5 | 2 | 8 | 7 | 11 | 34 | 2 | 1 |
| Follow-up | 91 | 54 | 13 | 0 | 19 | 5 | 42 | 32 | 4 | 13 |
| Progressive disease | 84 | 36 | 9 | 2 | 28 | 9 | 37 | 37 | 8 | 2 |
| Unclear | 3 | 3 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 2 |
| Total | 226 | |||||||||